Animal Gastroesophageal Reflux Disease Market to Reach USD 0.2 Bn by 2034, Driven by Rising Veterinary Care Awareness

Reports And Data
Animal Gastroesophageal Reflux Disease Market to reach USD 0.2B by 2034, driven by pet ownership, diagnostics, and veterinary care growth.
VANCOUVER, BC, CANADA, August 25, 2025 /EINPresswire.com/ -- The Animal Gastroesophageal Reflux Disease (GERD) Market is set to grow from USD 0.1 billion in 2024 to USD 0.2 billion by 2034, reflecting a steady CAGR of 7.20% over the forecast period. This growth is supported by increasing pet ownership, rising awareness of animal health, and advancements in veterinary diagnostics.Key Market Highlights
Market Size: USD 0.1 billion (2024) → USD 0.2 billion (2034)
CAGR: 7.20%
Largest Segment: Pharmaceuticals
Fastest-Growing Segment: Diagnostic services
Top Applications: Companion animal care and livestock health management
Regional Leader: North America
Fastest-Growing Region: Asia Pacific
Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/24934
Market Drivers
The market is expanding as more households adopt pets and prioritize veterinary care. According to the American Pet Products Association, 67% of U.S. households owned a pet in 2023. A similar trend is emerging in Asia, where pet adoption is growing rapidly in countries such as China and India.
Public initiatives are also driving growth. For instance, the USDA’s Animal Health Research Program has invested in research on animal diseases, including GERD, to improve treatment outcomes. Leading players such as Zoetis Inc., Boehringer Ingelheim, and Elanco Animal Health are also investing in research and product innovation.
A major development in 2024 was Zoetis’ launch of new pharmaceuticals targeting animal GERD, which quickly gained traction in the market.
Market Restraints
Despite strong growth potential, the market faces challenges due to regulatory and compliance requirements. The European Union’s Veterinary Medicines Regulation (EU 2019/6) places strict rules on veterinary drugs, raising costs and delaying approvals. In addition, there is a lack of standardized diagnostic protocols for GERD in animals, which may lead to misdiagnosis. Limited access to advanced diagnostic tools in developing countries also presents hurdles.
Market Segmentation
By Product Type
Pharmaceuticals: Expected to dominate, reaching USD 0.12 billion by 2034 (CAGR 6.8%). Demand is high for effective treatments like antacids and proton pump inhibitors.
Diagnostics: Fastest-growing, with a CAGR of 8.5%, expected to reach USD 0.05 billion by 2034, driven by AI-based tools that improve speed and accuracy of diagnosis.
Nutraceuticals & Surgical Devices: Gaining traction with increasing focus on preventive care and minimally invasive treatments.
By Application
Companion Animals: Largest segment, projected at USD 0.15 billion by 2034 (CAGR 7.0%). Growth is linked to the rise of pet humanization and demand for advanced veterinary care.
Livestock: Smaller but growing faster (CAGR 7.5%), expected to reach USD 0.05 billion by 2034, driven by the need to improve livestock productivity and health.
By End User
Veterinary Clinics: Largest share, expected to reach USD 0.1 billion by 2034 (CAGR 6.9%), supported by their widespread availability.
Animal Hospitals: Fastest-growing, with a CAGR of 7.8%, reaching USD 0.07 billion by 2034. Hospitals provide advanced diagnostics and treatments for complex conditions.
Research Institutes: Growing steadily due to rising investment in veterinary R&D.
By Distribution Channel
Veterinary Pharmacies: Largest segment, projected at USD 0.12 billion by 2034 (CAGR 6.7%).
Online Retail: Fastest-growing, with a CAGR of 8.2%, expected to hit USD 0.05 billion by 2034, fueled by convenience and growing e-commerce adoption.
Direct Sales: Steady growth, supported by personalized veterinary care.
Regional Outlook
North America: Expected to maintain leadership thanks to advanced veterinary infrastructure, high pet ownership, and strong investments in animal healthcare.
Asia Pacific: Projected as the fastest-growing region, with pet adoption and veterinary awareness on the rise in countries like India and China.
Europe: Growth shaped by strict regulations but supported by high standards of veterinary care.
Access Full Report Description with Research Methodology and Table of Contents @ https://www.reportsanddata.com/report-detail/animal-gastroesophageal-reflux-disease-market
Emerging Trends
The market is witnessing important technological and sustainability trends:
AI in Diagnostics: AI-based tools are improving detection accuracy by up to 30%, according to the American Veterinary Medical Association.
Sustainable Pharmaceuticals: Companies are focusing on eco-friendly and safe treatment solutions.
Animal Gastroesophageal Reflux Disease Competitive Strategies & Notable Developments
Top 10 Companies
Zoetis Inc.
Boehringer Ingelheim
Elanco Animal Health
Merck Animal Health
Bayer Animal Health
Virbac
Ceva Santé Animale
Vetoquinol
Dechra Pharmaceuticals
IDEXX Laboratories
Strategy
Top players in the Animal Gastroesophageal Reflux Disease Market are competing through strategic initiatives such as mergers and acquisitions, partnerships, and product innovations. For instance, Zoetis Inc. holds a significant market position due to its extensive product portfolio and strong distribution network. The company has been actively investing in R&D to innovate and expand its product offerings. Boehringer Ingelheim has been focusing on strategic partnerships to enhance its market presence. The company's collaboration with leading veterinary clinics has enabled it to expand its reach and improve its product offerings. Elanco Animal Health has been focusing on vertical integration to streamline its operations and improve its market position.
Animal Gastroesophageal Reflux Disease Market Segmentation
By Product Type
Pharmaceuticals
Diagnostics
Nutraceuticals
Surgical Devices
By Application
Companion Animals
Livestock
By End User
Veterinary Clinics
Animal Hospitals
Research Institutes
By Distribution Channel
Veterinary Pharmacies
Online Retail
Direct Sales
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/24934
Read More Related Report @
Waste To Energy Advanced Technologies Market https://www.reportsanddata.com/report-detail/waste-to-energy-advanced-technologies-market
Global Renewable Energy Advanced Technologies Market https://www.reportsanddata.com/report-detail/global-renewable-energy-advanced-technologies-market
Thin Film Pv Market https://www.reportsanddata.com/report-detail/thin-film-pv-market
B2B Courier Express Parcel Market https://www.reportsanddata.com/report-detail/b2b-courier-express-parcel-market
Laboratory Logistics Market https://www.reportsanddata.com/report-detail/laboratory-logistics-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Debanjan Biswas
Reports and Data
+91 80872 27888
purushottam@reportsanddata.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
